Paid Clinical Trials in Shreveport, LA
As of August 2026, 146 paid clinical trials are recruiting in Shreveport, Louisiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Shreveport offers studies at sites including LSU Health Sciences Center at Shreveport for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Endometrial Cancer, Heart Failure, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Shreveport
Trials by drug in Shreveport
Filter results
Newly added in Shreveport
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
136 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
ACP-204 in Adults With Alzheimer's Disease Psychosis
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Patient Retrospective Outcomes (PRO)
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Top Research Study Locations in Shreveport
Researchers run research studies in Shreveport, LA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| LSU Health Sciences Center at Shreveport | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 12 |
| LSU Health Shreveport | Adjustment Disorder, Apathy, Emphysema | 7 |
| Ochsner LSU Health - Cancer Treatment Center | Anatomic Stage II Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma | 6 |
| Louisiana State University Health Sciences Shreveport | COVID-19, Carcinoma, Non-Small-Cell Lung, Relapsed or Refractory Multiple Myeloma (RRMM) | 6 |
| Spine Institute of Louisiana | Adult Spinal Deformity, Degenerative Disc Disease, Degenerative Disc Disease (DDD) | 5 |
| CHRISTUS Highland Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 4 |
| Louisiana Research Center, LLC | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 4 |
| Louisiana State University | Breast Cancer, Lupus Nephritis, Parkinson's Disease | 4 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus | 3 |
| LSU Health Sciences Center | Chronic Kidney Diseases, Head and Neck Squamous Cell Carcinoma, Pulmonary Embolism | 3 |
| Louisiana Research Center | Obesity or Overweight, Crohn's Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease | 3 |
| Louisiana State University Health Shreveport | Aneurysm, Brain, Interstitial Lung Disease (ILD), Proteinuric Kidney Disease | 3 |
| Trials365, LLC | Cervical Cancer, Endometrial Adenocarcinoma, Endometrial Cancer | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 2 |
| Grace Research, LLC-Shreveport-64616 | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure | 2 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight With Diabetes | 2 |
| LSU Health Science Center Shreveport | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, PBC | 2 |
| LSU Health Shreveport Clinical Trials Office | Pneumococcal Disease | 2 |
| Louisiana Research Center - GastroIntestinal Associates | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Louisiana Spine Institute | Adult Spinal Deformity, Kyphosis, Scoliosis | 2 |
| Louisiana State University Health Sciences Center | Large B-cell Lymphoma, Non-Hodgkin Lymphoma, Normal and Diseased Tissue and Body Fluids Samples | 2 |
| Louisiana State University Health Sciences Center Shreveport | Irritability Associated With Autism Spectrum Disorder, Parkinson Disease | 2 |
| Northwest Louisiana Nephrology | Focal Segmental Glomerulosclerosis, Kidney Disease | 2 |
| Ochsner LSU Health Shreveport Ambulatory Care Center | Pneumococcal Disease | 2 |
Active & Upcoming Studies in Shreveport (2026)
Recruiting trials in Shreveport grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (46 active studies)
- A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma · Phase 3 · Janssen Research & Development, LLC
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy · Phase 3 · Boehringer Ingelheim
Diabetes & metabolic (12 active studies)
Cardiovascular (10 active studies)
- Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD · VA Office of Research and Development
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (9 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease · VIVEX Biologics, Inc.
Vaccines (1 active study)
Mental health & behavior (1 active study)
- Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. · Phase 3 · Louisiana State University Health Sciences Center Shreveport
Common conditions studied in Shreveport
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Endometrial Cancer (4 active studies)
- Heart Failure (4 active studies)
- Obesity (4 active studies)
- Adult Spinal Deformity (3 active studies)
- Cervical Cancer (3 active studies)
Leading research sponsors in Shreveport
- AstraZeneca
- Boehringer Ingelheim
- Merck Sharp & Dohme LLC
- Eli Lilly and Company
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Shreveport?
There are approximately 146 recruiting clinical trials in Shreveport, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Shreveport pay participants?
Most recruiting trials in Shreveport compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Shreveport?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Shreveport?
The most common conditions under active study in Shreveport include Anatomic Stage II Breast Cancer AJCC v8 (4), Endometrial Cancer (4), Heart Failure (4), Obesity (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Shreveport?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Shreveport on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Shreveport?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Shreveport?
Recruiting research sites in Shreveport include LSU Health Sciences Center at Shreveport, LSU Health Shreveport, Ochsner LSU Health - Cancer Treatment Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Shreveport right now?
The largest active categories in Shreveport are Cancer & tumors (46), Diabetes & metabolic (12), Cardiovascular (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.